Modulation of Adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 3, 2000, Pages 219-230

  Larrivée, Bruno ^a   Averill, Diana A ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Adriamycin; Cyclosporin A; Drug efflux; Hyperthermia; Multidrug resistance

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHO CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG TRANSPORT; HYPERTHERMIA; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033975806     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050033     Document Type: Article

References (59)

1. 1. Averill-Bates DA, Courtemanche B (1995) The effect of hyperthermia and verapamil on melphalan cytotoxicity and transport in multidrug resistant Chinese hamster ovary cells. Radiat Res 143: 17
2. 2. Bates DA, Mackillop WJ (1986) Hyperthermia, Adriamycin transport, and cytotoxicity in drug-sensitive and -resistant Chinese hamster ovary cells. Cancer Res 46: 5477
3. 3. Bates DA, Mackillop WJ (1990) The effect of hyperthermia in combination with melphalan on drug sensitive and drug resistant CHO cells in vitro. Br J Cancer 62: 183
4. 4. Bates DA, Henritzy LL, Loutfi A, Mackillop WJ (1987) The effect of hyperthermia on the cytotoxicity of melphalan in Chinese hamster ovary cells. Cancer Lett 34: 145
5. 5. Beck WT, Cirtain MC, Glover CJ, Felsted RL, Safa AR (1988) Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Biochem Biophys Res Commun 153: 959
6. 6. Capranico G, Kohn KW, Pommier Y (1990) Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin. Nucleic Acids Res 18: 6611
7. 7. Chambers SK, Hait WN, Kacinski BM, Keyes SR, Handshumacher RE (1989) Enhancement of anthracycline growth inhibition in parent and multidrug resistant Chinese hamster ovary cells by cyclosporin A and its analogues. Cancer Res 49: 6275
8. 8. Cleary I, Doherty G, Moran E, Clynes M (1997) The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol 53: 1493
9. 9. Coley HM, Twentyman PR, Workman P (1993) The efflux of anthracyclines in multidrug-resistant cell lines. Biochem Pharmacol 46: 1317
10. 10. Dahl O (1988) The interaction of hyperthermia and chemotherapy. Recent Results Cancer Res 107: 157
11. 11. Dahl O (1994) Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E (eds) Hyperthermia and oncology, vol 4. VSP, Utrecht, p 9
12. 12. Davis HL, David TE (1979) Daunorubicin and Adriamycin in cancer treatment; an analysis of their roles and limitations. Cancer Treat Rep 63: 809
13. 13. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ (1988) Multifactorial resistance to Adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48: 3595
14. 14. Doroshow JH (1986) Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Commun 135: 330
15. 15. Doroshow JH (1996) Anthracyclines and anthracenediones. In: Chabner BA, Longo DL (eds) Cancer chemotherapy and biotherapy: principles and practice, 2nd edn. Lippincott-Raven, Philadelphia, p 409
16. 16. Drewinko B, Loo TL, Brown B, Gottlieb JA, Freireich EJ (1976) Combination chemotherapy in vitro with Adriamycin. Observation of additive, antagonistic, and synergistic effects when used in two-drug combination on cultured human lymphoma cells. Cancer Biochem Biophys 1: 187
17. 17. Endicott J, Ling V (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 58: 137
18. 18. Fojo A, Akitama S, Gottesman M, Pastan I (1985) Reduced drug accumulation in multiple drug resistant human KB carcinoma cell lines. Cancer Res 45: 3002
19. 19. Goldberg H, Ling V, Wong PY, Skorecki K (1988) Reduced cyclosporin accumulation in multidrug resistant cells. Biochem Biophys Res Commun 152: 552
20. 20. Hahn GM (1979) Potential for therapy of drugs and hyperthermia. Cancer Res 39: 2264
21. 21. Hait WN, Stein JM, Koletsky AJ, Slater LM, Harding MW, Handschumacher RE (1987) Modulation of doxorubicin (DOX) resistance by cyclosporin A (CsA) and a non-immunosuppressive homolog. Proc Am Assoc Cancer Res 28: 298
22. 22. Herman TS, Cress AE, Sweets C, Gerner EW (1981) Reversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cells. Cancer Res 41: 3840
23. 23. Herman TS, Teicher BA, Cathcart KN, Kaufman ME, Lee JB, Lee MH (1988) Effect of hyperthermia on cis-diamminedichloroplatinum (II) and Pt(Rh-123)2 in a human squamous carcinoma cell line and a cis-diamminedichloroplatinum (II)-resistant subline. Cancer Res 48: 5101
24. 24. Hindenburg AA, Gervasoni JE Jr, Krishna S, Stewart VJ, Rosado M, Lutzky J, Bhalla K, Baker MA, Taub RN (1989) Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res 49: 4607
25. 25. Honess DJ, Bleehen NM (1988) Thermal enhancement of drug cytotoxicity in vivo and in vitro. Recent Results Cancer Res 109: 161
26. 26. Kartner R, Shales M, Riordan J, Ling V (1983) Daunorubicin resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res 43: 4413
27. 27. Keizer HG, Schuurhuis GJ, Broxterman HJ, Lankelma J, Schoonen WGEJ, Rijn F van, Pinedo HM, Joenje H (1989) Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured W-1573 human lung tumor cells. Cancer Res 49: 2988
28. 28. Kessel D, Wilbesding C (1984) Mode of action of calcium antagonists which alter anthracycline resistance. Biochem Pharmacol 33: 1157
29. 29. Lepock JR, Kruuv J (1993) Mechanism of thermal cytotoxicity. In: Gerner EW, Cetas TC (eds) Hyperthermia oncology 1992, vol 2. Arizona Board of Regents, Tucson, Arizona, p 9
30. 30. Li GC (1984) Thermal biology and physiology in clinical hyperthermia: current status and future needs. Cancer Res 44: 4886s
31. 31. Ling V (1992) P-glycoprotein and resistance to anticancer drugs. Cancer 69: 2603
32. 32. Ling V, Thompson LH (1973) Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83: 103
33. 33. Meador J, Sweet P, Stupecky M, Wtezel M, Murray S, Gupta S, Slater L (1987) Enhancement by cyclosporin A of daunorubicin efficacy in Ehrlich ascites carcinoma and murine hepatoma. Cancer Res 47: 6216
34. 34. Orlandi L, Zaffaroni N, Bearzatto A, Costa A, Supino R, Vaglini M, Silvestrini R (1995) Effect of melphalan and hyperthermia on cell cycle progression and cyclin B expression in human melanoma cells. Cell Prolif 28: 617
35. 35. Osieka R, Seeber S, Pannenbacker R, Soll D, Glatte P, Schmidt CG (1986) Enhancement of etoposide-induced cytotoxicity by cyclosporin A. Cancer Chemother Pharmacol 18: 198
36. 36. Powis G (1987) Anthracycline metabolism and free radical formation. In: Powis G, Prough RA (eds) Metabolism and action of anti-cancer drugs. Taylor and Francis, London, p 211
37. 37. Raaphorst GP, Doja S, Davis L, Stewart D, Ng CE (1996) A comparison of hyperthermia on cisplatin sensitization in human glioma and ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 37: 574
38. 38. Rice GC, Hahn GM (1987) Modulation of Adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting. Cancer Chemother Pharmacol 20: 183
39. 39. Saydjari R, Townsend C, Barranco SC, James E, Thompson JC (1986) Effects of cyclosporin A and difluoromethyl ornithine on the growth of hamster pancreatic cells in vitro. J Natl Cancer Inst 77: 1087
40. 40. Shoji Y, Fisher MH, Periasamy A, Heiman B, Juliano RL (1991) Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms. Cancer Lett 57: 209
41. 41. Sinha BK, Katki AC, Batist G, Cowan KH, Myers CE (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36: 793
42. 42. Sinha BK, Katki AC, Batist G, Cowan KH, Myers CE (1987) Differential formation of hydroxyl radicals by Adriamycin in sensitive and resistant MCF-7 human tumor cells: implication for the mechanism of action. Biochemistry 26: 3776
43. 43. Slater LM, Sweet P, Stupecky M, Wetzel MW, Gupta S (1986) Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest 77: 1405
44. 44. Sokolove MS (1994) Interactions of Adriamycin aglycones with mitochondria may mediate Adriamycin cardiotoxicity. Int J Biochem 26: 1341
45. 45. Tamai I, Safa AR (1991) Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 266: 1679
46. 46. Toffoli G, Sorio R, Gigante M, Corona G, Galligioni E, Boiocchi M (1997) Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposide. Br J Cancer 75: 715
47. 47. Towle LR (1994) Hyperthermia and drug resistance. In: Urano M, Douple E (eds) Hyperthermia and oncology, vol 4. VSP, Utrecht, p 91
48. 48. Tritton TR (1991) Cell surface actions of Adriamycin. Pharmacol Ther 49: 293
49. 49. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967
50. 50. Twentyman PR (1988) Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins. Br J Cancer 57: 254
51. 51. Twentyman PR (1992) Cyclosporins as drug resistance modifiers. Biochem Pharmacol 43: 109
52. 52. Twentyman PR, Fox NE, White DJG (1987) Cyclosporin A and its analogues as modifiers of Adriamycin and vincristine resistance in a multidrug human lung cancer cell line. Br J Cancer 56: 55
53. 53. Urano M, Douple E (1989) Hyperthermia and oncology, vol 2. Biology of thermal potentiation of radiotherapy. VSP, Utrecht
54. 54. Vayuvegula B, Slater L, Meador J, Gupta S (1988) Correlation of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. Cancer Chemother Pharmacol 22: 163
55. 55. Verweij J, Herweijer H, Oosterom R, Burg MEL van der, Planting ASTh, Seynaeve C, Stoter G, Nooter K (1991) A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin A in an attempt to reverse multidrug resistance. Br J Cancer 64: 361
56. 56. Wallner KE, De Gregorio MW, Li GC (1986) Hyperthermia potentiation of diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242
57. 57. Wallner KE, Banda M, Li GC (1987) Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 47: 1308
58. 58. Warner E, Tobe SW, Andrulis IL, Pei Y, Trachtenberg J, Skorecki KL (1995) Phase I-II study of vinblastine and oral cyclosporin A in metastatic renal carcinoma. Am J Clin Oncol 18: 251
59. 59. Williamham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effect of verapamil and other drugs. Cancer Res 46: 5941